ClearComplyAI Beta Tester Terms and Conditions
Effective Date: November 1, 2026
These ClearComplyAI Beta Tester Terms and Conditions (the “Agreement”) are entered into among New Jersey Innovation Institute, Inc. (“NJII”), Legal HIE Compliance Solutions LLC (“Legal HIE”), each an “Owner” and together the “Owners”; the organization identified during enrollment (the “Organization”); and each individual issued ClearComplyAI Beta credentials (a “Tester”). By clicking “I Agree,” activating credentials, or accessing the ClearComplyAI Beta Service after being presented with this Agreement, the accepting person represents that the person has authority to bind the Organization. Each Tester also agrees personally to the duties concerning credentials, confidentiality, data restrictions, prohibited uses, and Feedback.
This Agreement incorporates the ClearComply Beta Privacy Policy and the ClearComply Beta Cookies Policy. If there is a conflict, this Agreement controls regarding access, use, intellectual property, disclaimers, liability, and ClearComplyAI Beta obligations; the ClearComplyAI Beta Privacy Policy controls regarding privacy disclosures to the extent not inconsistent with this Agreement.
IMPORTANT ClearComplyAI BETA DATA WARNING: NO PHI, PART 2 RECORDS, PATIENT-IDENTIFYING INFORMATION, OR OTHER REGULATED DATA. The ClearComplyAI Beta Service is for non-production evaluation and Feedback only. Do not enter EHR screenshots, incident reports, real patient narratives, names, medical-record numbers, dates tied to actual individuals, credentials, confidential client information, or other sensitive or restricted data. Appropriately de-identify any scenario based on an actual case. Removing a name alone may not be sufficient to de-identify a scenario.
1. Key Definitions
- “Beta Service” means the pre-release ClearComplyAI Beta application, AI-enabled workflows, documentation, interfaces, test environment, Output, and related support made available for evaluation.
- “Customer Content” means prompts, questions, scenarios, documents, text, and other content submitted by or for the Organization, excluding Feedback and Usage Data. “Output” means responses, analyses, citations, templates, recommendations, or other material generated by the ClearComplyAI Beta Service.
- “Feedback” means evaluations, ratings, bug reports, corrections, test results, suggestions, and other comments concerning the ClearComplyAI Beta Service. “Usage Data” means technical, security, and analytical data concerning access and use, including account, session, device, feature-use, performance, error, and security-log information.
- “Regulated Data” means PHI or ePHI under HIPAA; records or patient-identifying information protected by 42 C.F.R. Part 2; information that identifies or could reasonably identify a patient or other individual; credentials, government identifiers, payment or financial information; sensitive personal data; confidential third-party information; and any other data the Owners identify as prohibited.
2. ClearComplyAI Beta Program; Term; No Charge
- The Organization may participate in ClearComplyAI Beta without a subscription or access fee. The initial ClearComplyAI Beta Period begins when the first authorized Tester’s credentials are activated and continues for eight (8) consecutive weeks. It may be extended only in additional 4-week blocks by mutual written agreement, including email approval by authorized representatives of the Organization and the Owners.
- The ClearComplyAI Beta Service is experimental. The Owners may modify, limit, suspend, reset, or discontinue any feature or access at any time. No service level, uptime, support, backup, data-export, correction, launch date, commercial availability, or feature commitment applies. Participation does not obligate the Organization to purchase or the Owners to offer a commercial service.
3. Limited License; Individual Credentials
- During the ClearComplyAI Beta Period, the Owners grant the Organization a limited, revocable, non-exclusive, non-transferable, non-sublicensable right to permit approved Testers to use the ClearComplyAI Beta Service solely for the Organization’s internal, non-production evaluation and to provide Feedback. No other right or license is granted.
- Each Tester must receive unique credentials from the Owners. Credentials are personal to the named Tester and may not be shared, pooled, transferred, posted, embedded in another system, or used by another person. Any additional employee, contractor, affiliate, or counsel who wishes to test must receive separate credentials and accept the then-current terms. The Organization is responsible for activity through its accounts and must promptly report suspected compromise and request deactivation when access is no longer needed.
4. Prohibited Uses
- Except as the Owners expressly authorize in writing, the Organization and each Tester shall not directly or indirectly:
- reverse engineer, decompile, disassemble, decode, extract, discover, or attempt to obtain source code, model weights, embeddings, system instructions or prompts, retrieval content, taxonomies, architecture, methods, security controls, or other non-public technical information;
- use prompt injection, jailbreaks, model extraction, scraping, crawling, automated queries, bots, scripts, APIs, load testing, vulnerability testing, or security circumvention;
- copy, modify, distribute, publish, sublicense, resell, mirror, host, benchmark publicly, or provide the ClearComplyAI Beta Service or non-public Output to a third party, or use it as a service bureau;
- use the ClearComplyAI Beta Service, Output, or ClearComplyAI Beta materials to train, fine-tune, ground, validate, benchmark, or improve another AI model, legal technology tool, compliance product, dataset, or competing service;
- submit Regulated Data, malware, infringing material, or information the Organization is not authorized to disclose; or
- use the ClearComplyAI Beta Service or Output for production operations, patient care, actual legal or compliance determinations, regulatory filings, deadlines, benefits or coverage decisions, employment decisions, or any other action materially affecting a person regardless of professional review.
- The absence of a technical restriction does not grant permission. The Owners may monitor access and activity to operate, secure, evaluate, enforce, and improve the ClearComplyAI Beta Service.
5. Weekly Feedback and Retesting
- Substantive, timely Feedback is material consideration for the no-fee ClearComplyAI Beta access. During each week of the ClearComplyAI Beta Period, the Organization will provide written Feedback through its Testers, including both positive and negative observations concerning legal or factual accuracy, citations, completeness, usability, workflow, performance, and defects. Testers may submit Feedback directly in the chat module, through other in-app feedback features, or by email to the address in Section 5.3. The separate feedback instructions and video explain these options. For legal-accuracy concerns, the Organization should identify supporting primary authority when reasonably available.
- The Organization will reasonably respond to follow-up questions and retest material issues after the Owners report a change or request confirmation. The Owners have sole discretion whether, when, and how to investigate, prioritize, correct, or use Feedback. The Owners may suspend or terminate access for insufficient participation. No Tester is entitled to compensation, attribution, royalties, employment, or ownership for testing or Feedback.
- For Feedback, support, security issues, or accidental submissions, email clearcomplybeta@njii.com.
6. Ownership; Feedback; Confidentiality
- As between the parties, the Owners collectively own all right, title, and interest in and to ClearComplyAI, the ClearComplyAI Beta Service, all software, models, prompts, workflows, retrieval methods, decision trees, legal and compliance content, templates, interfaces, designs, know-how, Usage Data, improvements, configurations, derivative works, and all related intellectual property rights. All rights not expressly granted are reserved.
- The Organization retains its rights in Customer Content it lawfully supplies. It grants the Owners and their service providers a worldwide, non-exclusive, royalty-free right to process Customer Content and Output as reasonably necessary to provide, secure, monitor, test, troubleshoot, evaluate, and improve the ClearComplyAI Beta Service; respond to Feedback; enforce this Agreement; and comply with law. Output may not be unique and may resemble material generated for others. Output may be used only for evaluation, verification, Feedback, and internal discussion, and not as final legal advice or for production use.
- The Owners collectively own all Feedback, however submitted, including through the chat module, other in-app features, or email. The Organization and each Tester irrevocably assign to the Owners all right, title, and interest in Feedback, including intellectual property rights. If an assignment is ineffective, they grant the Owners a perpetual, irrevocable, worldwide, transferable, sublicensable, fully paid, royalty-free license to use, modify, commercialize, and otherwise exploit the Feedback for any purpose without additional consent, attribution, or compensation.
- The ClearComplyAI Beta Service, non-public Output, product design, prompts and workflows, documentation, defects, security information, performance results, roadmaps, pricing, and non-public ClearComplyAI Beta communications are the Owners’ Confidential Information. The Organization may use and disclose that information only for the ClearComplyAI Beta evaluation to personnel with a need to know who are bound by protective confidentiality obligations. The Owners will protect permitted Customer Content and non-public Organization Feedback using reasonable care. Confidential Information excludes information that is public without breach, previously known without restriction, lawfully received from a third party, or independently developed. Required disclosures may be made to the minimum extent legally required. Neither party may publicly identify the other as a ClearComplyAI Beta participant or issue a testimonial, case study, press release, or public benchmark without written consent.
- Unauthorized use or disclosure of ClearComply materials or Confidential Information may cause irreparable harm. The affected Owner may seek injunctive or equitable relief in addition to other remedies.
7. Data Restrictions; Privacy; Security
- The ClearComplyAI Beta Service is not authorized for Regulated Data. This Agreement is not a HIPAA business associate agreement, a qualified service organization agreement under 42 C.F.R. Part 2, a data use agreement, or a substitute for any required privacy or security agreement. The Organization must ensure that test scenarios based on actual cases are appropriately de-identified. Testers must keep Regulated Data out of prompts, Feedback, screenshots, and support communications. The Owners have no duty to inspect Customer Content for Regulated Data and may delete or restrict prohibited content without liability. Any Tester or Organization that discovers Regulated Data in a submission must promptly report the incident to clearcomplybeta@njii.com without including or resending the data. The Organization remains responsible for its legal assessment, notifications, mitigation, and compliance obligations.
- The Owners may retain limited business contact, account, authentication, acceptance, device, and security-log information needed to issue and secure unique credentials, administer the ClearComplyAI Beta, investigate misuse, and maintain legal records. Personal-identifying information in Customer Content is prohibited and will not be intentionally retained for product-improvement use. If discovered, the Owners will use commercially reasonable efforts to remove it from active ClearComplyAI Beta systems, subject to technical feasibility, security and audit logs, backups, legal holds, and applicable law.
- Permitted Customer Content, Output, Usage Data, and Feedback may be processed, and, as applicable, stored or reviewed by authorized personnel and service providers to generate responses; operate, secure, support, troubleshoot, test, evaluate, and improve retrieval, source selection, instructions, workflows, guardrails, citations, templates, quality controls, and user experience; and develop and commercialize ClearComply. The Owners may retain and use Feedback, Usage Data, and aggregated or de-identified information that does not reasonably identify the Organization or a Tester.
- The Owners may use cloud, AI, authentication, analytics, monitoring, security, and support providers acting on their behalf. The Owners do not sell Customer Content or authorize unaffiliated providers to use it for their own independent commercial purposes. The Owners do not permit third-party AI model providers to use Customer Content or Output to train their models.
- The Owners may retain Output in a database under their control so that Testers can access and review prior sessions during the ClearComplyAI Beta Period.
- The Owners will maintain commercially reasonable administrative, technical, and organizational safeguards designed to protect the ClearComplyAI Beta Service and permitted Customer Content and consistent with generally accepted industry practices for comparable pre-release cloud services. No internet-connected or AI service is completely secure or continuously available, and the Owners do not warrant that a security incident, loss, disclosure, defect, or interruption will never occur. Each Tester must use secure, Organization-authorized devices and networks, protect credentials, and promptly report suspected incidents.
8. ClearComplyAI Beta Disclaimers; No Legal or Professional Advice
- The Owners have taken steps intended to incorporate selected statutes, regulations, official guidance, legal frameworks, and other relevant information into ClearComplyAI. The ClearComplyAI Beta Service nevertheless is a work in progress. Sources, retrieval, reasoning, citations, templates, recommendations, and technical components may be incomplete, outdated, inconsistent, unavailable, incorrectly configured, fabricated, or wrong, and may omit controlling facts, law, exceptions, or jurisdiction-specific requirements.
- TO THE MAXIMUM EXTENT PERMITTED BY LAW, THE ClearComplyAI BETA SERVICE, OUTPUT, DOCUMENTATION, SUPPORT, AND RELATED MATERIALS ARE PROVIDED “AS IS,” “AS AVAILABLE,” AND “WITH ALL FAULTS.” THE OWNERS DISCLAIM ALL EXPRESS, IMPLIED, STATUTORY, AND OTHER WARRANTIES, INCLUDING MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE, NON-INFRINGEMENT, ACCURACY, COMPLETENESS, CURRENCY, SECURITY, RELIABILITY, AVAILABILITY, LEGAL OR REGULATORY COMPLIANCE, AND PROFESSIONAL RESULTS. THE OWNERS DO NOT WARRANT THAT DEFECTS WILL BE CORRECTED OR THAT ACCESS WILL BE UNINTERRUPTED OR SECURE.
- ClearComplyAI provides educational and evaluation support only. It does not provide legal, compliance, medical, clinical, or other professional advice and does not create an attorney-client, fiduciary, professional, clinician-patient, or other advisory relationship with either Owner, Attorneys at Oscislawski LLC, or any associated attorney or professional. Communications through the ClearComplyAI Beta Service should not be assumed privileged. The Organization must independently verify all material Output, citations, and conclusions against current primary authority, source documents, applicable facts, and qualified professional judgment before any reliance or implementation.
9. Assumption of Risk; Release; Limitation of Liability
- THE ORGANIZATION AND EACH TESTER KNOWINGLY ASSUME THE RISKS OF ACCESSING, TESTING, USING, OR RELYING ON THE ClearComplyAI BETA SERVICE OR OUTPUT, INCLUDING ERROR, OMISSION, HALLUCINATION, DELAY, UNAVAILABILITY, DATA LOSS, SECURITY INCIDENT, INCORRECT LEGAL ANALYSIS, AND ACTION OR INACTION BASED ON OUTPUT. TO THE MAXIMUM EXTENT PERMITTED BY LAW, THEY RELEASE AND DISCHARGE THE OWNERS AND THEIR AFFILIATES, TRUSTEES, DIRECTORS, OFFICERS, MEMBERS, MANAGERS, EMPLOYEES, CONTRACTORS, LICENSORS, SERVICE PROVIDERS, SUCCESSORS, AND ASSIGNS (THE “RELEASED PARTIES”) FROM CLAIMS ARISING OUT OF OR RELATING TO THE ClearComplyAI BETA SERVICE, OUTPUT, TESTING, OR FEEDBACK, EXCEPT TO THE EXTENT A CLAIM CANNOT LAWFULLY BE RELEASED.
- TO THE MAXIMUM EXTENT PERMITTED BY LAW, NO RELEASED PARTY WILL BE LIABLE FOR INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, PUNITIVE, ENHANCED, OR CONSEQUENTIAL DAMAGES; LOST PROFITS, REVENUE, GOODWILL, OPPORTUNITY, OR DATA; SUBSTITUTE-SERVICE COSTS; REGULATORY FINES OR PENALTIES; FORENSIC, NOTICE, REMEDIATION, MONITORING, LEGAL, OR PROFESSIONAL COSTS; OR DAMAGES ARISING FROM RELIANCE ON OUTPUT. THE AGGREGATE LIABILITY OF ALL RELEASED PARTIES, COLLECTIVELY, ARISING OUT OF OR RELATING TO THIS AGREEMENT, THE ClearComplyAI BETA SERVICE, OUTPUT, TESTING, PRIVACY POLICY, COOKIES POLICY, OR FEEDBACK WILL NOT EXCEED ONE HUNDRED U.S. DOLLARS ($100). THIS IS ONE CAP FOR ALL CLAIMS, USERS, EVENTS, AND RELEASED PARTIES.
- These limitations apply regardless of legal theory and even if a limited remedy fails of its essential purpose. They do not limit the Organization’s or a Tester’s obligations concerning unauthorized use, infringement, confidentiality, Regulated Data, indemnification, or compliance with law. Any claim must be filed within one (1) year after it accrued, to the maximum extent permitted by law. Each Released Party is an intended third-party beneficiary of these protections.
10. Indemnification
The Organization will defend, indemnify, and hold harmless the Released Parties from third-party claims, investigations, liabilities, losses, penalties, damages, and reasonable attorneys’ fees arising out of or relating to Customer Content; submission of Regulated Data; breach of this Agreement; unauthorized or prohibited use; credential sharing or compromise caused by the Organization or its personnel; infringement, privacy, confidentiality, or other rights violations; or the Organization’s or a Tester’s violation of law, professional duty, negligence, or willful misconduct. The Organization may not settle a claim in a manner that admits wrongdoing by, imposes obligations on, or fails to fully release a Released Party without written consent.
11. Suspension; Termination
The Owners may suspend, restrict, reset, or terminate access immediately, with or without notice, for suspected breach, security or legal risk, credential sharing, submission of prohibited data, inadequate Feedback, abusive or competitive use, maintenance, product changes, or convenience. The Organization may end participation at any time by ceasing use and notifying NJII. Upon expiration or termination, access and licenses end immediately; the Owners may disable credentials and have no obligation to preserve, export, return, or restore Customer Content or Output. Provisions concerning restrictions, ownership, confidentiality, data rights, disclaimers, release, liability, indemnification, disputes, and matters that by their nature should survive will survive.
12. Potential Commercial Subscription Discount
- After completion of the initial 8-week ClearComplyAI Beta Period or any mutually approved extension, the Organization will be eligible to be considered for a twenty-five percent (25%) discount on the first annual term of a commercially available version of ClearComplyAI. The discount is subject to unilateral approval by the Owners in their sole discretion, based on the quality, quantity, candor, specificity, usefulness, and timeliness of Feedback; reasonable retesting; compliance with this Agreement; and the Organization’s overall contribution to the ClearComplyAI Beta.
- No discount is earned merely by receiving credentials or completing the calendar period. A discount exists only if the Owners issue a written commercial offer, and commercial use requires a separate subscription agreement. The discount has no cash value, is non-transferable, and does not obligate the Owners to launch a commercial version, accept the Organization as a customer, or support Regulated Data.
13. General Terms
- This Agreement is governed by New Jersey law, without regard to conflict-of-laws principles. The parties submit to the exclusive jurisdiction of the state courts in Morris County, New Jersey, and the United States District Court for the District of New Jersey. TO THE MAXIMUM EXTENT PERMITTED BY LAW, EACH PARTY WAIVES TRIAL BY JURY, AND ALL CLAIMS MUST BE BROUGHT ONLY IN AN INDIVIDUAL CAPACITY, NOT AS A CLASS, COLLECTIVE, CONSOLIDATED, MASS, REPRESENTATIVE, OR PRIVATE-ATTORNEY-GENERAL ACTION.
- The Owners may update this Agreement, the Privacy Policy, or the Cookies Policy for legal, security, operational, or ClearComplyAI Beta-program reasons. Material changes may be presented electronically and may require renewed acceptance. The Organization and Testers may not assign or transfer this Agreement or credentials without written consent; either Owner may assign its rights in connection with commercialization, restructuring, financing, or a transfer of the relevant business or assets. If a provision is unenforceable, it will be enforced to the maximum lawful extent and the remainder will continue. A waiver must be in writing. This Agreement and the enrollment record are the complete agreement concerning ClearComplyAI Beta and supersede prior discussions on that subject. A separately signed agreement expressly addressing the same subject controls to the extent of conflict.
- Nothing creates a partnership, agency, employment, fiduciary, attorney-client, clinical, or joint-venture relationship between the Organization or a Tester and an Owner, or alters the separate relationship between NJII and Legal HIE. References to the Owners collectively do not by themselves impose joint or several liability. Electronic signatures, click-through assent, and electronic records may be used to form and prove this Agreement, including the agreement version, identity, Organization, timestamp, IP address, and authentication event.
- Legal notices to the Owners. Send notices to NJII by email to the Compliance Officer at clearcomplybeta@njii.com. Send notices to Legal HIE at Legal HIE Compliance Solutions, 782 Alexander Road, PO Box 1, Princeton, New Jersey 08540, Attn: Legal HIE.